• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

缺乏来自高效液相色谱32P后标记法检测人类子宫内膜中他莫昔芬-DNA加合物的证据。

Lack of evidence from HPLC 32P-post-labelling for tamoxifen-DNA adducts in the human endometrium.

作者信息

Carmichael P L, Sardar S, Crooks N, Neven P, Van Hoof I, Ugwumadu A, Bourne T, Tomas E, Hellberg P, Hewer A J, Phillips D H

机构信息

Imperial College School of Medicine, Division of Biomedical Sciences, Molecular Toxicology, London, UK.

出版信息

Carcinogenesis. 1999 Feb;20(2):339-42. doi: 10.1093/carcin/20.2.339.

DOI:10.1093/carcin/20.2.339
PMID:10069474
Abstract

Tamoxifen is associated with an increased incidence of endometrial cancer in women. It is also a potent carcinogen in rat liver and forms covalent DNA adducts in this tissue. A previous study exploring DNA adducts in human endometria, utilizing thin layer chromatography 32P-postlabelling, found no evidence for adducts in tamoxifen-treated women [Carmichael,P.L., Ugwumadu,A.H.N., Neven,P., Hewer,A.J., Poon,G.K. and Phillips,D.H. (1996) Cancer Res., 56, 1475-1479]. However, subsequent work utilizing HPLC 32P-post-labelling [Hemminki,K., Ranjaniemi,H., Lindahl,B. and Moberger,B. (1996) Cancer Res., 56, 4374-4377] suggested that very low levels could be detected. We have sought to investigate this question further by reproducing the HPLC methodology at two centres, and analysing endometrial DNA from 20 patients treated with 20 mg/day tamoxifen for between 22 and 65 months. Liver DNA isolated from tamoxifen-treated rats was used as a positive control. We found no convincing evidence for tamoxifen-derived DNA adducts in human endometrium. HPLC elution profiles of post-labelled DNA from tamoxifen-treated women were indistinguishable from those obtained with DNA from 14 untreated women and from six women taking toremifene, an analogue of tamoxifen.

摘要

他莫昔芬与女性子宫内膜癌发病率的增加有关。它在大鼠肝脏中也是一种强效致癌物,并在该组织中形成共价DNA加合物。先前一项利用薄层层析32P后标记法探索人类子宫内膜中DNA加合物的研究,未发现他莫昔芬治疗女性中有加合物的证据[卡迈克尔,P.L.,乌格武马杜,A.H.N.,内文,P.,休厄尔,A.J.,潘,G.K.和菲利普斯,D.H.(1996年)《癌症研究》,56,1475 - 1479]。然而,随后利用高效液相色谱32P后标记法的研究[赫明基,K.,兰亚涅米,H.,林达尔,B.和莫伯格,B.(1996年)《癌症研究》,56,4374 - 4377]表明可以检测到极低水平的加合物。我们试图通过在两个中心重现高效液相色谱方法,并分析20例接受每日20毫克他莫昔芬治疗22至65个月的患者的子宫内膜DNA,进一步研究这个问题。从他莫昔芬治疗的大鼠中分离的肝脏DNA用作阳性对照。我们没有发现令人信服的证据表明人类子宫内膜中存在他莫昔芬衍生的DNA加合物。他莫昔芬治疗女性的后标记DNA的高效液相色谱洗脱图谱与14名未治疗女性以及6名服用托瑞米芬(他莫昔芬类似物)女性的DNA所获得的洗脱图谱无法区分。

相似文献

1
Lack of evidence from HPLC 32P-post-labelling for tamoxifen-DNA adducts in the human endometrium.缺乏来自高效液相色谱32P后标记法检测人类子宫内膜中他莫昔芬-DNA加合物的证据。
Carcinogenesis. 1999 Feb;20(2):339-42. doi: 10.1093/carcin/20.2.339.
2
Electrospray ionization-tandem mass spectrometry and 32P-postlabeling analyses of tamoxifen-DNA adducts in humans.人三苯氧胺-DNA加合物的电喷雾电离串联质谱分析和³²P后标记分析
J Natl Cancer Inst. 2004 Jul 21;96(14):1099-104. doi: 10.1093/jnci/djh195.
3
Lack of evidence for tamoxifen- and toremifene-DNA adducts in lymphocytes of treated patients.治疗患者淋巴细胞中未发现他莫昔芬和托瑞米芬-DNA加合物的证据。
Carcinogenesis. 2000 Apr;21(4):845-7. doi: 10.1093/carcin/21.4.845.
4
Formation of tamoxifen-DNA adducts in human endometrial explants exposed to alpha-hydroxytamoxifen.暴露于α-羟基他莫昔芬的人子宫内膜外植体中他莫昔芬-DNA加合物的形成。
Chem Res Toxicol. 2005 May;18(5):889-95. doi: 10.1021/tx050019l.
5
Identification of tamoxifen-DNA adducts in the endometrium of women treated with tamoxifen.
Carcinogenesis. 2000 Aug;21(8):1461-7.
6
Determination of tamoxifen--DNA adducts in leukocytes from breast cancer patients treated with tamoxifen.他莫昔芬治疗的乳腺癌患者白细胞中他莫昔芬-DNA加合物的测定
Chem Res Toxicol. 2004 Dec;17(12):1577-83. doi: 10.1021/tx049930c.
7
Evaluation of tamoxifen and alpha-hydroxytamoxifen 32P-post-labelled DNA adducts by the development of a novel automated on-line solid-phase extraction HPLC method.通过开发一种新型自动化在线固相萃取高效液相色谱法评估他莫昔芬和α-羟基他莫昔芬32P后标记的DNA加合物。
Carcinogenesis. 1998 Jun;19(6):1061-9. doi: 10.1093/carcin/19.6.1061.
8
32P-postlabelled DNA adducts in liver obtained from women treated with tamoxifen.从接受他莫昔芬治疗的女性身上获取的肝脏中经32P后标记的DNA加合物
Carcinogenesis. 1995 Jul;16(7):1651-4. doi: 10.1093/carcin/16.7.1651.
9
Analysis of tamoxifen-induced DNA adducts by 32P-postlabelling assay using different chromatographic techniques.
J Chromatogr B Biomed Sci Appl. 1997 Mar 28;691(1):155-60. doi: 10.1016/s0378-4347(96)00421-5.
10
Excision of tamoxifen-DNA adducts by the human nucleotide excision repair system.
Cancer Res. 2000 May 15;60(10):2607-10.

引用本文的文献

1
Molecular mechanisms of tamoxifen-associated endometrial cancer (Review).他莫昔芬相关子宫内膜癌的分子机制(综述)
Oncol Lett. 2015 Apr;9(4):1495-1501. doi: 10.3892/ol.2015.2962. Epub 2015 Feb 12.
2
Endoxifen and other metabolites of tamoxifen inhibit human hydroxysteroid sulfotransferase 2A1 (hSULT2A1).他莫昔芬的内昔芬及其他代谢产物可抑制人羟基类固醇磺基转移酶2A1(hSULT2A1)。
Drug Metab Dispos. 2014 Nov;42(11):1843-50. doi: 10.1124/dmd.114.059709. Epub 2014 Aug 25.
3
Tamoxifen-DNA adduct formation in monkey and human reproductive organs.
他莫昔芬-DNA 加合物在猴和人生殖器官中的形成。
Carcinogenesis. 2014 May;35(5):1172-6. doi: 10.1093/carcin/bgu029. Epub 2014 Feb 5.
4
Progesterone action in endometrial cancer, endometriosis, uterine fibroids, and breast cancer.孕激素在子宫内膜癌、子宫内膜异位症、子宫肌瘤和乳腺癌中的作用。
Endocr Rev. 2013 Feb;34(1):130-62. doi: 10.1210/er.2012-1043. Epub 2013 Jan 9.
5
Peroxidase-mediated dealkylation of tamoxifen, detected by electrospray ionization-mass spectrometry, and activation to form DNA adducts.通过电喷雾电离质谱检测到的过氧化酶介导的他莫昔芬脱烷基化,以及形成 DNA 加合物的激活作用。
Free Radic Biol Med. 2012 Jan 15;52(2):340-7. doi: 10.1016/j.freeradbiomed.2011.10.433. Epub 2011 Oct 18.
6
The effect of tamoxifen and raloxifene on estrogen metabolism and endometrial cancer risk.他莫昔芬和雷洛昔芬对雌激素代谢和子宫内膜癌风险的影响。
J Steroid Biochem Mol Biol. 2011 Sep;126(3-5):78-86. doi: 10.1016/j.jsbmb.2011.05.001. Epub 2011 May 10.
7
Differences in metabolite-mediated toxicity of tamoxifen in rodents versus humans elucidated with DNA/microsome electro-optical arrays and nanoreactors.利用DNA/微粒体电光阵列和纳米反应器阐明他莫昔芬在啮齿动物与人类中代谢物介导的毒性差异。
Chem Res Toxicol. 2009 Feb;22(2):341-7. doi: 10.1021/tx8004295.
8
Tamoxifen induces expression of immune response-related genes in cultured normal human mammary epithelial cells.他莫昔芬可诱导培养的正常人乳腺上皮细胞中免疫反应相关基因的表达。
Cancer Res. 2009 Feb 1;69(3):1150-5. doi: 10.1158/0008-5472.CAN-08-2806. Epub 2009 Jan 20.
9
Translesion synthesis past tamoxifen-derived DNA adducts by human DNA polymerases eta and kappa.人DNA聚合酶η和κ跨越他莫昔芬衍生的DNA加合物进行跨损伤合成。
Biochemistry. 2006 Oct 3;45(39):12167-74. doi: 10.1021/bi0608461.
10
Bioactivation of Selective Estrogen Receptor Modulators (SERMs).选择性雌激素受体调节剂(SERMs)的生物活化
Chem Res Toxicol. 2006 Sep;19(9):1125-37. doi: 10.1021/tx060126v.